DNAPrint Genomics, Inc.
DNAG
Rank in Stocks
#35171
DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis... DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.
Share Price
$0.000001
Last synced: 2026-11-09
Market Cap
$630.33
Change (1 day)
-95.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade DNAPrint Genomics, Inc. (DNAG)
Category
Healthcare
Operating Margin for DNAPrint Genomics, Inc. (DNAG)
Operating Margin as of November 2026 TTM: -364.45%
According to DNAPrint Genomics, Inc.'s latest financial reports, its current operating margin (TTM) is -364.45%. At the end of 2006 the company had an operating margin of -364.45%.
Operating Margin history for DNAPrint Genomics, Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -364.45% | 0.00% |
| 2006 | -364.45% | -0.29% |
| 2005 | -365.50% | -186.12% |
| 2004 | 424.42% | -51.69% |
| 2003 | 878.58% | -37.96% |
| 2002 | 1,416.20% | -92.01% |
| 2001 | 17,733.34% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.11% |
US
|
|
| -149.01% | -99.59% |
US
|
|
| 25.57% | -100.07% |
AU
|
|
| 31.23% | -100.09% |
BE
|
|
| 29.35% | -100.08% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about DNAPrint Genomics, Inc.'s operating margin
What is DNAPrint Genomics, Inc.'s operating margin?
DNAPrint Genomics, Inc.'s operating margin is -364.45%, as of Nov 2026.
What was DNAPrint Genomics, Inc.'s operating margin in 2006?
In 2006, DNAPrint Genomics, Inc.'s operating margin was -364.45%, compared with -365.50% in 2005.
How has DNAPrint Genomics, Inc.'s operating margin changed since 2001?
From 2001 to 2006, DNAPrint Genomics, Inc.'s operating margin was highest in 2001 (17,733.34%) and lowest in 2005 (-365.50%).
How does DNAPrint Genomics, Inc.'s operating margin compare with similar companies?
DNAPrint Genomics, Inc.'s operating margin (-364.45%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.